Share chart Compugen Ltd
Extended chart
Simple chart
About
Compugen Ltd.- это публично торгуемая компания по прогнозированию и разработке лекарств, находящаяся на клинической стадии, со штаб-квартирой в Израиле, акции которой торгуются на NASDAQ Capital Market и на Тель-Авивской фондовой бирже. Компания Compugen была основана в 1993 году как поставщик вычислительных услуг по поиску лекарств. Изначально Compugen выступал в качестве поставщика услуг для фармацевтических компаний, поставляя свое программное обеспечение и вычислительные услуги для прогнозирования различных типов биологических явлений. more details| EBITDA | -0.0279 |
|---|---|
| EV/EBITDA | -11.83 |
| IPO date | 2000-08-11 |
| ISIN | IL0010852080 |
| Industry | Life Sciences Tools & Services |
| P/BV | 9.66 |
| P/S | 492.27 |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Выручка | 0.002 |
| Див.доход ао | 0 |
| Сайт | http://www.cgen.com |
| Цена ао | 2.01 |
| Число акций ао | 0.08763 млрд |
| Change price per day: | 0% (1.6) |
|---|---|
| Change price per week: | +5.26% (1.52) |
| Change price per month: | +5.26% (1.52) |
| Change price per 3 month: | -8.57% (1.75) |
| Change price per half year: | -8.57% (1.75) |
| Change price per year: | -10.11% (1.78) |
| Change price per 3 year: | -44.44% (2.88) |
| Change price per 5 year: | -88.93% (14.46) |
| Change price per 10 year: | -78.84% (7.56) |
| Change price per year to date: | +4.58% (1.53) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Taylor Frigon Capital Management LLC | 1894712 | 2.12 |
| Rock Springs Capital Management, LP | 1289990 | 1.45 |
| Renaissance Technologies, LLC | 1121100 | 1.26 |
| Macquarie Group Limited | 1000000 | 1.12 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 940000 | 1.05 |
| Morgan Stanley | 771669 | 0.86 |
| Sphera Funds Management Ltd. | 769239 | 0.86 |
| Rothschild Investment LLC | 351100 | 0.39 |
| UBS Group AG | 314697 | 0.35 |
| Millennium Management LLC | 278460 | 0.31 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| ARK Israel Innovative Technology ETF | 2.16226 | 14.19 | 1.21688 |
| SPDR S&P International Small Cap ETF | 0.01472 | 8.94 | 3.10348 |
SPDR Portfolio Developed World ex-US ETF
|
0.00091 | 2.31 | 3.28401 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Dorit Amitay | Vice President of Human Resources | N/A | 1968 (57 years) |
| Ms. Yvonne Naughton | Head of Investor Relations & Corporate Communications | N/A | |
| Dr. Anat Cohen-Dayag Ph.D. | CEO, President & Director | 796.52k | 1967 (58 years) |
| Mr. Eran Ben Dor | General Counsel & Corporate Secretary | N/A | |
| Dr. Zurit Levine Ph.D. | Senior Vice President of Technology Innovation | 345.7k | 1968 (57 years) |
| Dr. Eran Ophir Ph.D. | Chief Scientific Officer | N/A | 1978 (47 years) |
| Dr. Pierre Ferre Ph.D. | Vice President of Preclinical Development | 415.1k | 1977 (48 years) |
| Dr. Yaron Turpaz M.B.A., Ph.D. | Senior VP & Senior Advisor of Data and Informatics Solutions | N/A | 1971 (54 years) |
| Rivka Schwartz | Vice President Research and Discovery | N/A | |
| Mr. David Silberman CPA | Chief Financial Officer | 1984 (41 year) |
Address: Israel, Holon , Building D - open in Google maps, open in Yandex maps
Website: http://www.cgen.com
Website: http://www.cgen.com
